Quarterly report pursuant to Section 13 or 15(d)

Diluted Loss Per Share

v3.21.2
Diluted Loss Per Share
3 Months Ended
Nov. 30, 2020
Earnings Per Share [Abstract]  
DILUTED LOSS PER SHARE
17. DILUTED LOSS PER SHARE

The Company’s potentially dilutive instruments are convertible debentures and stock options and share purchase warrants. Conversion of these instruments would have been anti-dilutive for the periods presented and consequently, no adjustment was made to basic loss per share to determine diluted loss per share. These instruments could potentially dilute earnings per share in future periods.


For the three months ended November 30, 2020 and 2019, the following stock options, share purchase warrants and convertible securities were excluded from the computation of diluted loss per share as the result of the computation was anti-dilutive:


    Three months ended November 30,
2020
    Three months ended November 30,
2019
 
             
Share purchase options     9,470,000       9,808,333  
Share purchase warrants     47,379,348       45,347,469  
Convertible securities     97,608,979       16,909,330  
      154,458,327       72,065,132